As discussed in Part I, the authors identified IgA responses to BDNF and TSPAN7 autoantigens in ovarian cancer and found that recombinant BDNF and TSPAN7 IgA antibodies reduce xenograft tumor growth. Here, BDNF is linked to ovarian cancer.